PT - JOURNAL ARTICLE AU - Germann, Jürgen AU - Gouveia, Flavia Venetucci AU - Brentani, Helena AU - Bedford, Saashi A. AU - Tullo, Stephanie AU - Chakravarty, M. Mallar AU - Devenyi, Gabriel A. TI - Involvement of the habenula in the pathophysiology of autism spectrum disorder AID - 10.1101/2021.04.08.21255122 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.08.21255122 4099 - http://medrxiv.org/content/early/2021/04/10/2021.04.08.21255122.short 4100 - http://medrxiv.org/content/early/2021/04/10/2021.04.08.21255122.full AB - The habenula is a small epithalamic structure that has rich widespread connections to multiple cortical, subcortical and brainstem regions. It has been identified as the central structure modulating the reward value of social interactions, behavioral adaptation, sensory integration and circadian rhythm. Autism spectrum disorder is characterized by social communication deficits, restricted interests and repetitive behaviors, and frequently associated with altered sensory perception and mood and sleep disorders. The habenula is implicated in all these behaviors and results of preclinical studies suggest a possible involvement of the habenula in the pathophysiology of this disorder. Using anatomical magnetic resonance imaging and automated segmentation we show that the habenula is significantly enlarged in children and adults with ASD compared to age matched controls. The present study is first to provide evidence of the involvement of the Hb in the pathophysiology of ASD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGAD acknowledges that this work was supported in part by funding provided by Brain Canada, in partnership with Health Canada, for the Canadian Open Neuroscience Platform Initiative. This research was enabled in part by support provided by SciNet (www.scinethpc.ca) and Compute Canada (www.computecanada.ca).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The dataset analysed during the current study (Autism Brain Imaging Data Exchange, ABIDE I &; ABIDE II) is publicly available at http://fcon_1000.projects.nitrc.org/indi/abide/. For detailed demographics, imaging acquisition parameters, local institutional review boards and written informed consent, please visit (http://fcon_1000.projects.nitrc.org/indi/abide/).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset analysed during the current study (Autism Brain Imaging Data Exchange, ABIDE I & ABIDE II) is publicly available at http://fcon_1000.projects.nitrc.org/indi/abide.The tool used in this study for automatic segmentation of the habenula is freely available at https://github.com/CoBrALab/MAGeTbrain. The processed data are available from the corresponding author upon reasonable request.